June 14, 2021 ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
June 12, 2021 Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
June 11, 2021 Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
June 8, 2021 Development of immunoprecipitation – two-dimensional liquid chromatography – mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients
June 2, 2021 PD-L1 detection on circulating tumor-derived extracellular vesicles (T-EVs) from patients with lung cancer